rs587779297
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000179.3(MSH6):c.3957delA(p.Ala1320GlnfsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000179.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lynch syndrome 5 Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
not provided Pathogenic:1
This deletion of one nucleotide in MSH6 is denoted c.3957delA at the cDNA level and p.Ala1320GlnfsX7 (A1320QfsX7) at the protein level. The normal sequence, with the base that is deleted in brackets, is GAAA[delA]GCAA. The deletion causes a frameshift which changes an Alanine to a Glutamine at codon 1320, and creates a premature stop codon at position 7 of the new reading frame. Although this variant has not, to our knowledge, been reported in the literature as a germline variant, it is predicted to cause loss of normal protein function through protein truncation. Even though nonsense-mediated decay is not expected to occur, due to the position of the variant, it is significant as the last 41 amino acids are lost and replaced with 6 incorrect amino acids. The disrupted region at the end of the gene is located within the binding site of MSH2 in the ATPase domain (Kariola 2002, Warren 2007, Kansikas 2011). Based on currently available evidence, we consider this deletion to be pathogenic. -
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ala1320Glnfs*7) in the MSH6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 41 amino acid(s) of the MSH6 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MSH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 428325). This variant disrupts a region of the MSH6 protein in which other variant(s) (p.Leu1330Valfs*12) have been determined to be pathogenic (PMID: 14520694, 19851887, 21155762, 24440087). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.3957delA pathogenic mutation, located in coding exon 9 of the MSH6 gene, results from a deletion of one nucleotide at position 3957, causing a translational frameshift with a predicted alternate stop codon (p.A1320Qfs*7). Frameshifts are typically deleterious in nature, however, this frameshift occurs at the 3' terminus of MSH6, is not expected to trigger nonsense-mediated mRNA decay, and impacts only the last 41 amino acids of the protein. But based on internal data, another downstream truncating mutation (p.R1331*) has been classified as pathogenic and was reported in multiple individuals with hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome, which indicates the importance of this region (Plaschke J et al. Eur J Hum Genet. 2006;14(5):561-6; Sjursen W, J. Med. Genet. 2010 Sep; 47(9):579-85; van Lier MG, J. Pathol. 2012 Apr; 226(5):764-74). This alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at